CJS Securities Initiates Coverage on Transcat (NASDAQ:TRNS)

Analysts at CJS Securities began coverage on shares of Transcat (NASDAQ:TRNS) in a report issued on Tuesday, Briefing.com reports. The brokerage set an “outperform” rating and a $115.00 price target on the scientific and technical instruments company’s stock. CJS Securities‘s price target suggests a potential upside of 38.01% from the stock’s previous close.

Several other equities research analysts also recently issued reports on TRNS. Weiss Ratings restated a “sell (d+)” rating on shares of Transcat in a research report on Tuesday, August 25th. Northland Securities raised Transcat from a “market perform” rating to an “outperform” rating and set a $95.00 target price on the stock in a research report on Wednesday, October 21st. Two analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $105.00.

Transcat Trading Up 1.7%

TRNS stock opened at $83.33 on Tuesday. Transcat has a one year low of $50.23 and a one year high of $100.00. The stock has a market cap of $782.47 million, a price-to-earnings ratio of 225.22 and a beta of 0.66. The company has a fifty day moving average price of $86.46 and a two-hundred day moving average price of $81.10. The company has a debt-to-equity ratio of 0.36, a current ratio of 2.49 and a quick ratio of 2.11.

Transcat (NASDAQ:TRNS) last issued its quarterly earnings data on Tuesday, August 4th. The scientific and technical instruments company reported $0.51 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.13. The company had revenue of $92.95 million for the quarter, compared to analyst estimates of $86.55 million. Transcat had a net margin of 0.99% and a return on equity of 5.56%. Equities analysts anticipate that Transcat will post 1.74 EPS for the current year.

Insider Activity

In other Transcat news, Director Christopher P. Gillette sold 504 shares of the stock in a transaction that occurred on Friday, August 7th. The shares were sold at an average price of $94.23, for a total transaction of $47,491.92. Following the transaction, the director owned 200 shares in the company, valued at $18,846. This represents a 71.59% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Craig Cairns bought 1,050 shares of the stock in a transaction dated Thursday, August 6th. The shares were acquired at an average cost of $93.97 per share, for a total transaction of $98,668.50. Following the completion of the acquisition, the director directly owned 1,480 shares of the company’s stock, valued at approximately $139,075.60. This trade represents a 244.19% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. 1.80% of the stock is owned by insiders.

Institutional Trading of Transcat

Large investors have recently modified their holdings of the stock. Integrated Wealth Concepts LLC bought a new stake in Transcat in the second quarter worth approximately $32,000. Persistent Asset Partners Ltd acquired a new position in Transcat in the second quarter valued at approximately $52,000. GAMMA Investing LLC boosted its holdings in shares of Transcat by 133.6% during the 3rd quarter. GAMMA Investing LLC now owns 1,030 shares of the scientific and technical instruments company’s stock worth $91,000 after buying an additional 589 shares in the last quarter. Squarepoint Ops LLC boosted its holdings in shares of Transcat by 9.0% during the 2nd quarter. Squarepoint Ops LLC now owns 8,794 shares of the scientific and technical instruments company’s stock worth $816,000 after buying an additional 728 shares in the last quarter. Finally, Corient Private Wealth LP boosted its holdings in shares of Transcat by 9.1% during the 2nd quarter. Corient Private Wealth LP now owns 9,509 shares of the scientific and technical instruments company’s stock worth $882,000 after buying an additional 791 shares in the last quarter. 98.34% of the stock is owned by institutional investors and hedge funds.

Transcat Company Profile

Transcat, Inc (NASDAQ: TRNS) provides calibration, compliance, and measurement services for organizations that rely on accurate test and measurement equipment. The company supports customers in regulated industries, including life sciences, aerospace and defense, energy, manufacturing, and other industrial markets.

Its service offerings include laboratory and onsite calibration, repair, validation, and asset-management services. Transcat calibrates a broad range of equipment used to measure temperature, pressure, electrical and electronic properties, radio frequency signals, dimensional characteristics, and other technical parameters.